Inspire Medical Systems, Inc. (INSP) Stock Forecast
INSP analyst forecast
as of October 17, 2026- Analyst consensus
- Hold 3.22 / 5 from 18 analysts
- Price target
- $68.00 average of analyst targets
- Upside to target
- −1.1% from the latest close
- Next earnings
- November 2, 2026 EPS estimate $0.10
- 52-week range
- $40.05 – $143.99
INSP analyst ratings
18 analystsNumber of analysts at each rating.
INSP price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
INSP earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.09 | −$0.13 | $0.17 | $0.38 | −76.1% | 14 |
| Current fiscal year (2026) | $1.25 | $1.17 | $1.34 | $2.42 | −48.4% | 14 |
| Next fiscal year (2027) | $1.54 | $1.33 | $1.78 | $1.25 | +22.9% | 15 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
INSP revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $204.3M | $202.8M | $207.0M | −9.0% | 17 |
| Current fiscal year (2026) | $853.9M | $840.1M | $861.9M | −6.4% | 17 |
| Next fiscal year (2027) | $887.2M | $859.2M | $908.4M | +3.9% | 17 |
INSP EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
INSP revenue: reported and forecast
INSP EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.14 | $0.09 | $0.09 | $0.09 | $0.09 | −35.4% | 2 up · 8 down |
| Current fiscal year (2026) | $0.90 | $1.25 | $1.25 | $1.25 | $1.25 | +39.5% | 2 up · 0 down |
| Next fiscal year (2027) | $1.26 | $1.54 | $1.54 | $1.55 | $1.54 | +21.7% | 2 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
INSP earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; INSP beat in 12 of 12.
What analysts expect from INSP
18 analysts cover Inspire Medical Systems; their consensus rating is hold (3.22 on a 1–5 scale, where 5 is a strong buy). The average price target is $68.00, 1.1% below the latest close of $68.79. Analysts expect earnings of $1.25 per share for 2026, −48.4% from a year earlier. For 2027 the average estimate is $1.54 per share on revenue of $887.2 million. Inspire Medical Systems beat the EPS estimate in 12 of the last 12 quarters.
Related: INSP income statement, INSP key metrics, INSP chart. See the INSP stock overview for the latest quote and news.
INSP forecast FAQ
What is Inspire Medical Systems's price target?
The average analyst price target for Inspire Medical Systems is $68.00, 1.1% below the latest close of $68.79.
Is Inspire Medical Systems a buy, hold or sell?
Of 18 analysts covering Inspire Medical Systems, 4 rate it a strong buy, 0 a buy, 11 a hold, 2 a sell and 1 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Inspire Medical Systems's EPS forecast?
Analysts forecast $1.25 per share for 2026 (range $1.17 to $1.34); for 2027 the estimate is $1.54.
What is Inspire Medical Systems's revenue forecast?
The average revenue estimate for 2026 is $853.9 million, growth of −6.4%; for 2027 it is $887.2 million.
When does Inspire Medical Systems report earnings?
Inspire Medical Systems is expected to report results for the quarter ending September 30, 2026 on November 2, 2026 after the market closes; the EPS estimate is $0.10.
Does Inspire Medical Systems usually beat earnings estimates?
Inspire Medical Systems reported EPS at or above the analyst estimate in 12 of the last 12 quarters.